calendar>>November 19. 2009 Juche 98
Efficient "HCV-PHA" Developed
Pyongyang, November 19 (KCNA) -- The Medical Biology Research Institute under the Academy of Medical Science of the DPRK has succeeded in developing "HCV-PHA", a reagent for diagnosis of hepatitis type C virus anti-body, with the help of up-to-date technology of genetic recombination.

It is an ecto-diagnosis reagent for examining an anti-body in blood by using an antigen related to the hepatitis type C virus.

It, manufactured with a virus genome which was separated and refined from the serum of a patient as the main, makes it possible to identify in a scientific way the hepatitis type C virus anti-body the identification of which had been regarded as difficult.

The "HCV-PHA", whose sensitiveness and peculiarity have been confirmed through clinical test, is applied to the public health organs across the country.

Copyright (C) KOREA NEWS SERVICE(KNS) All Rights Reserved.